List of Massachusetts Biotechnology Companies: $100M to $250M Revenue

Technology
Content Syndication
Direct Mail
Sales Development
- Sales Development
  
  Outbound SDR
  SDR-Team-as-a-Service with targeted multi-channel outreach and strategic sales playbooks.
  
  Inbound SDR
  Trained staff for responsive lead management and brand representation.
  
  Data Solutions
  Custom research and accurate data enrichment services.
How It Works
- HOW IT WORKS
  
  Orchestrated Outbound
  Multi-channel outbound success through coordinated touchpoints.
  
  Campaign Strategy
  Deliver of the right message to the right contact on the right channel.
  
  Research Overview
  Custom research and enrichment done by trained data experts.
- Ideal Customer Profile
  Specific and formalized targeting to support go-to-market strategies.
  
  Ads
  How we use advertising to create demand for client products and services.
Case Studies
Company
- COMPANY
  
  About Us
  CIENCE at a glance.
  
  Executive Team
  Meet the Executive Team
  
  Awards & Reviews
  Recognitions for CIENCE from third-party sources.
  
  Philosophy
  The CIENCE Way and corporate core values.
  
  Contact Us
  Ways to reach CIENCE directly.
- LEARN
  
  Podcast
  Our own Enterprise Sales Development podcast with expert guests.
  
  Blog
  All content produced by CIENCE.
  
  CIENCEpedia
  The CIENCE Wikipedia of common acronyms and terms used in our space.
  
  Press Releases
  Press releases and CIENCE updates.

Book a meeting

Companies Database

>

>

>

>

>

Revenues $100 Million to $250 Million

Company Name

Industry

Location

Revenue

Employees

Oxford Immunotec

United States, Massachusetts

$100M to $250M

201-500

United States, Massachusetts

$100M to $250M

201-500

Cambridge Healthtech Institute

United States, Massachusetts

$100M to $250M

51-200

Kymera Therapeutics

United States, Massachusetts

$100M to $250M

51-200

Kaleido Biosciences

United States, Massachusetts

$100M to $250M

51-200

Masy BioServices, an Alcami company

United States, Massachusetts

$100M to $250M

51-200

Syndax Pharmaceuticals

United States, Massachusetts

$100M to $250M

51-200

United States, Massachusetts

$100M to $250M

51-200

United States, Massachusetts

$100M to $250M

51-200

SQZ Biotechnologies

United States, Massachusetts

$100M to $250M

51-200

Rapid Micro Biosystems

United States, Massachusetts

$100M to $250M

51-200

Boston Biomedical Associates | Now Avania

United States, Massachusetts

$100M to $250M

51-200

United States, Massachusetts

$100M to $250M

51-200

United States, Massachusetts

$100M to $250M

51-200

Argonaut Technologies

United States, Massachusetts

$100M to $250M

51-200

Spero Therapeutics

United States, Massachusetts

$100M to $250M

11-50

United States, Massachusetts

$100M to $250M

11-50

United States, Massachusetts

$100M to $250M

11-50

United States, Massachusetts

$100M to $250M

11-50

United States, Massachusetts

$100M to $250M

11-50